IMNOVID Capsules (Hard Gelatin)

Pomalidomide
2mg
CELGENE EUROPE BV.,
Pack size 21's
Dispensing mode POM
Source NETHERLANDS
AgentCITY PHARMACY CO.
Retail Price 49598.00 AED

Indications

IMNOVID Capsules (Hard Gelatin) is used for: Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Pomalidomide :

Mechanism of Action

Promalidomide is an immunomodulatory agent with antineoplastic activity. It is shown to inhibit the proliferation and induce apoptosis of various tumour cells. Furthermore, promalidomide enhances T cell and natural killer (NK) cell-mediated immunity and inhibited the production of pro-inflammatory cytokines, like TNF-alpha or IL-6, by monocytes. The primary target of promalidomide is thought to be the protein cereblon. It binds to this target and inhibits ubiquitin ligase activity. It is also a transcriptional inhibitor of COX2.

Note

IMNOVID 2mg Capsules (Hard Gelatin) manufactured by CELGENE EUROPE BV.,. Its generic name is Pomalidomide. IMNOVID is availble in United Arab Emirates. Farmaco UAE drug index information on IMNOVID Capsules (Hard Gelatin) is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Pomalidomide :